Breaking News Instant updates and real-time market news.

MRK

Merck

$74.87 /

-0.005 (-0.01%)

17:53
11/30/21
11/30
17:53
11/30/21
17:53

Merck says FDA panel vote on COVID antiviral a 'positive outcome'

Merck and Ridgeback Biotherapeutics provided a statement at the conclusion of the U.S. Food and Drug Administration's Antimicrobial Drugs Advisory Committee regarding the Emergency Use Authorization application for molnupiravir, an investigational oral antiviral medicine, for the treatment of mild to moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing who are at high risk for progressing to severe COVID-19 and/or hospitalization. The Advisory Committee voted 13-10 that the known and potential benefits of molnupiravir outweigh its known and potential risks for the treatment of mild to moderate COVID-19 in high risk adult patients who are within five days of symptom onset. The FDA is not bound by the committee's guidance but takes its advice into consideration. "The positive outcome of today's FDA Advisory Committee meeting, following a comprehensive review of molnupiravir, including the compelling data from the MOVe-OUT study demonstrating a significant reduction in hospitalizations and deaths, is a critical step toward bringing this promising oral medicine for COVID-19 to appropriate patients in the U.S. With the continued spread of the virus and the emergence of variants, additional treatments for COVID-19 are urgently needed. That is why we are moving with speed and rigor to pursue authorizations and to accelerate broad global access to this investigational medicine," said Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories. "We are grateful to the members of the Advisory Committee who reviewed our application, as well as to the patients and investigators who participated in our clinical trials, and we will continue to work with the FDA as the agency completes its review."

  • 30

    Nov

  • 03

    Dec

  • 04

    Dec

  • 07

    Dec

  • 08

    Dec

  • 10

    Dec

  • 21

    Dec

  • 03

    Feb

  • 21

    Mar

  • 28

    Mar

OTHER BREAKING NEWS FROM THE FLY

Recommendations
Hannover Re price target lowered to EUR 145.70 from EUR 146 at Barclays » 15:19
01/20/22
01/20
15:19
01/20/22
15:19
HVRRY

Hannover Re

$98.53 /

-0.31 (-0.31%)

Barclays analyst Ivan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HVRRY Hannover Re
$98.53 /

-0.31 (-0.31%)

11/05/21 Credit Suisse
Hannover Re price target raised to EUR 177 from EUR 172 at Credit Suisse
10/27/21 Societe Generale
Hannover Re downgraded to Hold from Buy at Societe Generale
10/21/21 Societe Generale
Hannover Re downgraded to Hold from Buy at Societe Generale
10/20/21 Credit Suisse
Hannover Re price target lowered to EUR 172 from EUR 174 at Credit Suisse
Options
Texas Capital options imply 4.7% move in share price post-earnings » 15:19
01/20/22
01/20
15:19
01/20/22
15:19
TCBI

Texas Capital

$61.00 /

-2.23 (-3.53%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TCBI Texas Capital
$61.00 /

-2.23 (-3.53%)

TCBI Texas Capital
$61.00 /

-2.23 (-3.53%)

01/18/22 BofA
Texas Capital reinstated with a Neutral at BofA
09/02/21 Wedbush
Texas Capital downgraded to Neutral at Wedbush
09/02/21 Janney Montgomery Scott
Janney cuts Texas Capital to Neutral on longer than expected turnaround timeline
09/02/21 Raymond James
Texas Capital price target lowered to $75 from $78 at Raymond James
TCBI Texas Capital
$61.00 /

-2.23 (-3.53%)

TCBI Texas Capital
$61.00 /

-2.23 (-3.53%)

Recommendations
EDF price target lowered to EUR 13.70 from EUR 17 at Barclays » 15:19
01/20/22
01/20
15:19
01/20/22
15:19
ECIFY

EDF

$1.82 /

-0.06 (-3.19%)

Barclays analyst Dominic…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ECIFY EDF
$1.82 /

-0.06 (-3.19%)

01/19/22 JPMorgan
EDF downgraded to Underweight from Overweight at JPMorgan
01/17/22 BofA
EDF downgraded to Underperform from Buy at BofA
01/17/22 HSBC
EDF downgraded to Hold from Buy at HSBC
12/31/21 Barclays
EDF price target lowered to EUR 17 from EUR 18 at Barclays
Recommendations
Cellnex Telecom price target lowered to EUR 65 from EUR 67 at Barclays » 15:18
01/20/22
01/20
15:18
01/20/22
15:18
CLLNY

Cellnex Telecom

$24.09 /

+0.22 (+0.92%)

Barclays analyst Simon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CLLNY Cellnex Telecom
$24.09 /

+0.22 (+0.92%)

09/27/21 Citi
Cellnex Telecom downgraded to Sell from Neutral at Citi
09/20/21 Credit Suisse
Cellnex Telecom price target raised to EUR 70 from EUR 65.76 at Credit Suisse
09/20/21 RBC Capital
Cellnex Telecom initiated with an Outperform at RBC Capital
09/09/21 JPMorgan
Cellnex Telecom price target raised to EUR 76 from EUR 72 at JPMorgan
Recommendations
Beazley price target raised to 531 GBp from 462 GBp at Barclays » 15:17
01/20/22
01/20
15:17
01/20/22
15:17
BZLYF

Beazley

$6.37 /

+ (+0.00%)

Barclays analyst Ivan…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BZLYF Beazley
$6.37 /

+ (+0.00%)

BZLYF Beazley
$6.37 /

+ (+0.00%)

11/09/21 Berenberg
Beazley price target raised to 490 GBp from 460 GBp at Berenberg
11/08/21 Citi
Beazley price target raised by 8% to 495 GBp at Citi
09/13/21 Barclays
Beazley price target raised to 429 GBp from 387 GBp at Barclays
08/25/21 Goldman Sachs
Beazley initiated with a Buy at Goldman Sachs
Periodicals
Carlyle Group mulls sale of Titan acquisition, Bloomberg reports » 15:16
01/20/22
01/20
15:16
01/20/22
15:16
CG

Carlyle Group

$51.64 /

+1.05 (+2.08%)

Carlyle Group is mulling…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

12/17/21 Deutsche Bank
Carlyle Group price target raised to $72 from $70 at Deutsche Bank
12/16/21 BofA
Carlyle Group initiated with a Buy at BofA
12/16/21 BofA
Carlyle Group initiated with a Buy at BofA
11/02/21 Citi
Carlyle Group price target raised to $73 from $66 at Citi
CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

  • 10
    Nov
  • 19
    May
  • 12
    Mar
CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

CG Carlyle Group
$51.64 /

+1.05 (+2.08%)

Recommendations
ASML price target raised to EUR 900 from EUR 800 at Barclays » 15:16
01/20/22
01/20
15:16
01/20/22
15:16
ASML

ASML

$719.87 /

+20.34 (+2.91%)

Barclays analyst Andrew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$719.87 /

+20.34 (+2.91%)

ASML ASML
$719.87 /

+20.34 (+2.91%)

15:09 Today UBS
ASML price target lowered to EUR 685 from EUR 720 at UBS
01/19/22 Summit Insights
ASML secular growth story remains intact, says Summit Insights
01/13/22 Credit Suisse
ASML resumed with an Outperform at Credit Suisse
12/20/21 Morgan Stanley
ASML initiated with an Overweight at Morgan Stanley
ASML ASML
$719.87 /

+20.34 (+2.91%)

Recommendations
Richemont price target raised to CHF 184 from CHF 169 at UBS » 15:13
01/20/22
01/20
15:13
01/20/22
15:13
CFRUY

Richemont

$15.37 /

+0.78 (+5.35%)

UBS analyst Zuzanna Pusz…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CFRUY Richemont
$15.37 /

+0.78 (+5.35%)

01/18/22 Morgan Stanley
Richemont price target raised to CHF 165 from CHF 152 at Morgan Stanley
01/04/22 Barclays
Richemont price target raised to CHF 155 from CHF 150 at Barclays
12/21/21 Bryan Garnier
Richemont upgraded to Buy from Neutral at Bryan Garnier
11/17/21 Stifel
Richemont upgraded to Buy from Hold at Stifel
CFRUY Richemont
$15.37 /

+0.78 (+5.35%)

Recommendations
DCC plc price target raised to 7,900 GBp from 7,700 GBp at UBS » 15:12
01/20/22
01/20
15:12
01/20/22
15:12
DCCPY

DCC plc

$40.75 /

+ (+0.00%)

UBS analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Recommendations
Burberry price target raised to 1,928 GBp from 1,855 GBp at UBS » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
BURBY

Burberry

$25.39 /

+1.25 (+5.18%)

UBS analyst Zuzanna Pusz…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BURBY Burberry
$25.39 /

+1.25 (+5.18%)

05:33 Today Kepler Cheuvreux
Burberry upgraded to Buy from Hold at Kepler Cheuvreux
12/20/21 Morgan Stanley
Burberry price target lowered to 1,900 GBp from 2,000 GBp at Morgan Stanley
11/15/21 UBS
Burberry price target raised to 1,845 GBp from 1,800 GBp at UBS
11/12/21 RBC Capital
Burberry price target raised to 1,980 GBp from 1,950 GBp at RBC Capital
Periodicals
Xilinx-AMD deal on course for approval from China's SAMR, Dealreporter says » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
XLNX

Xilinx

$190.00 /

+0.97 (+0.51%)

, AMD

AMD

$126.11 /

-2.18 (-1.70%)

AMD's (AMD) proposed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

12/15/21 Deutsche Bank
Xilinx price target raised to $207 from $195 at Deutsche Bank
10/28/21 Truist
Xilinx price target raised to $180 from $143 at Truist
10/28/21 Wells Fargo
Xilinx price target raised to $190 from $140 at Wells Fargo
10/28/21 Deutsche Bank
Xilinx price target raised to $195 from $155 at Deutsche Bank
AMD AMD
$126.11 /

-2.18 (-1.70%)

04:47 Today Piper Sandler
AMD downgraded to Neutral from Overweight at Piper Sandler
01/18/22 Cowen
AMD price target raised to $150 from $145 at Cowen
01/13/22 Mizuho
AMD price target raised to $150 from $135 at Mizuho
01/12/22 Barclays
AMD price target raised to $148 from $135 at Barclays
XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

XLNX Xilinx
$190.00 /

+0.97 (+0.51%)

AMD AMD
$126.11 /

-2.18 (-1.70%)

Recommendations
British American Tobacco price target lowered to 3,600 GBp at UBS » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
BTI

British American Tobacco

$42.76 /

-0.1 (-0.23%)

UBS analyst Nik Oliver…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

01/18/22 Stifel
Stifel says IQOS patent win a 'positive' development for Philip Morris, Altria
01/10/22 Barclays
British American Tobacco price target raised to 3,400 GBp at Barclays
12/20/21 Citi
Citi opens 'Positive Catalyst Watch' on British American Tobacco shares
12/08/21 UBS
British American Tobacco price target raised to 3,700 GBp from 3,500 GBp at UBS
BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

BTI British American Tobacco
$42.76 /

-0.1 (-0.23%)

Options
Peoples United Financial options imply 3.1% move in share price post-earnings » 15:11
01/20/22
01/20
15:11
01/20/22
15:11
PBCT

People's United

$19.55 /

-0.795 (-3.91%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PBCT People's United
$19.55 /

-0.795 (-3.91%)

PBCT People's United
$19.55 /

-0.795 (-3.91%)

07/22/21 Wedbush
M&T Bank price target lowered to $158 from $171 at Wedbush
05/18/21 Compass Point
People's United price target raised to $19.50 from $18.50 at Compass Point
05/10/21 Stephens
Dime Community upgraded to Overweight at Stephens following 'solid' Q1
04/06/21 Seaport Global
People's United downgraded on pending buyout at Seaport Global
PBCT People's United
$19.55 /

-0.795 (-3.91%)

Recommendations
ASML price target lowered to EUR 685 from EUR 720 at UBS » 15:09
01/20/22
01/20
15:09
01/20/22
15:09
ASML

ASML

$718.88 /

+19.35 (+2.77%)

UBS analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASML ASML
$718.88 /

+19.35 (+2.77%)

ASML ASML
$718.88 /

+19.35 (+2.77%)

01/19/22 Summit Insights
ASML secular growth story remains intact, says Summit Insights
01/13/22 Credit Suisse
ASML resumed with an Outperform at Credit Suisse
12/20/21 Morgan Stanley
ASML initiated with an Overweight at Morgan Stanley
10/21/21 UBS
ASML price target lowered to EUR 720 from EUR 740 at UBS
ASML ASML
$718.88 /

+19.35 (+2.77%)

Recommendations
Britvic price target lowered to 885 GBp from 945 GBp at Deutsche Bank » 15:08
01/20/22
01/20
15:08
01/20/22
15:08
BTVCY

Britvic

$25.31 /

+0.012 (+0.05%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BTVCY Britvic
$25.31 /

+0.012 (+0.05%)

01/18/22 Deutsche Bank
Britvic price target raised to 945 GBp from 940 GBp at Deutsche Bank
12/13/21 Barclays
Britvic initiated with an Equal Weight at Barclays
11/30/21 RBC Capital
Britvic price target raised to 890 GBp from 870 GBp at RBC Capital
11/26/21 JPMorgan
Britvic price target raised to 1,120 GBp from 1,075 GBp at JPMorgan
Recommendations
Elior Group price target lowered to EUR 8.10 from EUR 8.50 at Deutsche Bank » 15:08
01/20/22
01/20
15:08
01/20/22
15:08
ELROF

Elior Group

$6.95 /

+ (+0.00%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ELROF Elior Group
$6.95 /

+ (+0.00%)

11/26/21 Citi
Elior Group price target raised to EUR 9 from EUR 8 at Citi
11/01/21 Goldman Sachs
Elior Group downgraded to Neutral from Buy at Goldman Sachs
10/25/21 UBS
Elior Group price target raised to EUR 6.50 from EUR 6 at UBS
10/13/21 Deutsche Bank
Elior Group price target raised to EUR 8.50 from EUR 7 at Deutsche Bank
Recommendations
Edenred price target lowered to EUR 51.50 from EUR 53.50 at Deutsche Bank » 15:08
01/20/22
01/20
15:08
01/20/22
15:08
EDNMY

Edenred

$23.26 /

+0.06 (+0.26%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
EDNMY Edenred
$23.26 /

+0.06 (+0.26%)

15:07 Today Deutsche Bank
Edenred price target lowered to EUR 8.10 from EUR 8.50 at Deutsche Bank
01/18/22 Berenberg
Edenred price target raised to EUR 35 from EUR 30 at Berenberg
10/06/21 HSBC
Edenred upgraded to Buy from Hold at HSBC
07/28/21 Morgan Stanley
Edenred price target raised to EUR 49 from EUR 48 at Morgan Stanley
Recommendations
Antofagasta price target lowered to 1,250 GBp from 1,280 GBp at Deutsche Bank » 15:06
01/20/22
01/20
15:06
01/20/22
15:06
ANFGF

Antofagasta

$20.32 /

+0.8347 (+4.28%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANFGF Antofagasta
$20.32 /

+0.8347 (+4.28%)

05:35 Today Liberum
Antofagasta downgraded to Sell from Hold at Liberum
01/17/22 UBS
Antofagasta upgraded to Neutral from Sell at UBS
01/14/22 Deutsche Bank
Antofagasta price target lowered to 1,280 GBp from 1,300 GBp at Deutsche Bank
01/14/22 Barclays
Antofagasta price target raised to 1,100 GBp from 1,050 GBp at Barclays
Recommendations
Credit Agricole price target raised to EUR 17 from EUR 16 at Deutsche Bank » 15:05
01/20/22
01/20
15:05
01/20/22
15:05
CRARY

Credit Agricole

$7.61 /

-0.09 (-1.17%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CRARY Credit Agricole
$7.61 /

-0.09 (-1.17%)

11/12/21 Morgan Stanley
Credit Agricole price target lowered to EUR 15 from EUR 15.50 at Morgan Stanley
11/11/21 JPMorgan
Credit Agricole price target lowered to EUR 16 from EUR 17 at JPMorgan
10/18/21 Barclays
Credit Agricole price target raised to EUR 15.90 from EUR 15.50 at Barclays
09/10/21 JPMorgan
BNP Paribas downgraded to Neutral from Overweight at JPMorgan
Recommendations
Societe Generale price target raised to EUR 41 from EUR 37 at Deutsche Bank » 15:04
01/20/22
01/20
15:04
01/20/22
15:04
SCGLY

Societe Generale

$7.64 /

-0.15 (-1.93%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SCGLY Societe Generale
$7.64 /

-0.15 (-1.93%)

SCGLY Societe Generale
$7.64 /

-0.15 (-1.93%)

01/07/22 Credit Suisse
Societe Generale price target raised to EUR 40 from EUR 38 at Credit Suisse
01/07/22 Morgan Stanley
Societe Generale price target raised to EUR 39 from EUR 37 at Morgan Stanley
01/06/22 JPMorgan
Societe Generale price target raised to EUR 38 from EUR 37 at JPMorgan
12/08/21 Barclays
Societe Generale upgraded to Overweight from Equal Weight at Barclays
Options
Bank OZK options imply 3.5% move in share price post-earnings » 15:04
01/20/22
01/20
15:04
01/20/22
15:04
OZK

Bank OZK

$48.09 /

-0.65 (-1.33%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OZK Bank OZK
$48.09 /

-0.65 (-1.33%)

OZK Bank OZK
$48.09 /

-0.65 (-1.33%)

06/04/21 Wells Fargo
Bank OZK upgraded to Overweight from Equal Weight at Wells Fargo
04/14/21 Citi
Bank OZK price target raised to $40 from $37 at Citi
03/08/21 Truist
Bank OZK price target raised to $45 from $37 at Truist
01/26/21 Citi
Bank OZK price target raised to $37 from $32 at Citi
OZK Bank OZK
$48.09 /

-0.65 (-1.33%)

Recommendations
BNP Paribas price target raised to EUR 75 from EUR 66 at Deutsche Bank » 15:03
01/20/22
01/20
15:03
01/20/22
15:03
BNPQY

BNP Paribas

$36.93 /

-0.59 (-1.57%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

01/19/22 DZ Bank
BNP Paribas upgraded to Buy from Hold at DZ Bank
01/06/22 JPMorgan
BNP Paribas price target raised to EUR 69 from EUR 63 at JPMorgan
12/21/21 Kepler Cheuvreux
BNP Paribas upgraded to Buy from Hold at Kepler Cheuvreux
12/08/21 Barclays
BNP Paribas price target raised to EUR 57.60 from EUR 52.60 at Barclays
BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

BNPQY BNP Paribas
$36.93 /

-0.59 (-1.57%)

Conference/Events
Oppenheimer healthcare analysts hold an analyst/industry conference call » 15:00
01/20/22
01/20
15:00
01/20/22
15:00
ASND

Ascendis Pharma

$113.25 /

-5.42 (-4.57%)

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

01/13/22 Wedbush
Ascendis Pharma price target lowered to $186 from $191 at Wedbush
01/06/22 Cowen
Ascendis Pharma initiated with a Market Perform at Cowen
12/08/21 Wells Fargo
Ascendis Pharma initiated with an Overweight at Wells Fargo
11/19/21 Morgan Stanley
Morgan Stanley assumes Ascendis Pharma at Overweight, sees upcoming catalyst
ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

  • 02
    Sep
ASND Ascendis Pharma
$113.25 /

-5.42 (-4.57%)

Options
Altice USA put volume heavy and directionally bearish » 14:55
01/20/22
01/20
14:55
01/20/22
14:55
ATUS

Altice USA

$15.49 /

+0.035 (+0.23%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

01/18/22 Exane BNP Paribas
Altice USA downgraded yesterday to Underperform at Exane BNP Paribas
01/03/22 Wolfe Research
Altice USA cut to Peer Perform at Wolfe Research as cable's competition rises
01/03/22 Wolfe Research
Altice USA downgraded to Peer Perform from Outperform at Wolfe Research
12/15/21 Pivotal Research
Altice USA price target lowered to $22 from $30 at Pivotal Research
ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

  • 24
    Aug
ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

ATUS Altice USA
$15.49 /

+0.035 (+0.23%)

Options
SVB Capital II options imply 4.6% move in share price post-earnings » 14:49
01/20/22
01/20
14:49
01/20/22
14:49
SIVB

SVB Financial

$662.61 /

+8.62 (+1.32%)

Pre-earnings options…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

01/13/22 Morgan Stanley
NatWest Group, SVB Financial added as top bank picks at Morgan Stanley
01/10/22 Morgan Stanley
SVB Financial assumed with an Overweight at Morgan Stanley
01/10/22 Odeon Capital
SVB Financial downgraded to Hold from Buy at Odeon Capital
01/03/22 Barclays
SVB Financial price target raised to $789 from $755 at Barclays
SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

  • 10
    Aug
  • 23
    Mar
SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

SIVB SVB Financial
$662.61 /

+8.62 (+1.32%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.